Candel Therapeutics, Inc.CADLNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+16.8%
5Y CAGR+26.7%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+16.8%/yr
Annual compound
5Y CAGR
+26.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$125.19M+17.2%
2024$106.87M+159.4%
2023$41.20M-47.5%
2022$78.52M-12.0%
2021$89.20M+133.0%
2020$38.28M-16.6%
2019$45.90M-